The University of Chicago Header Logo

Connection

Maria-Luisa Alegre to Antigens, CD

This is a "connection" page, showing publications Maria-Luisa Alegre has written about Antigens, CD.
Connection Strength

0.583
  1. Transgenic expression of CTLA-4 controls lymphoproliferation in IL-2-deficient mice. J Immunol. 2004 Nov 01; 173(9):5415-24.
    View in: PubMed
    Score: 0.053
  2. CTLA-4 engagement regulates NF-kappaB activation in vivo. Eur J Immunol. 2002 Aug; 32(8):2095-104.
    View in: PubMed
    Score: 0.045
  3. Cutting edge: targeted ligation of CTLA-4 in vivo by membrane-bound anti-CTLA-4 antibody prevents rejection of allogeneic cells. J Immunol. 2002 Jul 15; 169(2):633-7.
    View in: PubMed
    Score: 0.045
  4. T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol. 2001 Dec; 1(3):220-8.
    View in: PubMed
    Score: 0.043
  5. Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice. Am J Transplant. 2001 May; 1(1):38-46.
    View in: PubMed
    Score: 0.042
  6. Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase. J Immunol. 2001 Mar 15; 166(6):3900-7.
    View in: PubMed
    Score: 0.041
  7. Transplantation and the CD28/CTLA4/B7 pathway. Transplant Proc. 2001 Feb-Mar; 33(1-2):209-11.
    View in: PubMed
    Score: 0.041
  8. Role of STAT6 signaling in the induction and long-term maintenance of tolerance mediated by CTLA4-Ig. Transplant Proc. 2001 Feb-Mar; 33(1-2):214-6.
    View in: PubMed
    Score: 0.041
  9. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance. J Immunol. 2000 Nov 15; 165(10):5580-7.
    View in: PubMed
    Score: 0.040
  10. Expression and function of CTLA-4 in Th1 and Th2 cells. J Immunol. 1998 Oct 01; 161(7):3347-56.
    View in: PubMed
    Score: 0.035
  11. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J Exp Med. 1998 Jul 06; 188(1):199-204.
    View in: PubMed
    Score: 0.034
  12. Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J Immunol. 1996 Dec 01; 157(11):4762-70.
    View in: PubMed
    Score: 0.031
  13. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts. J Immunol. 1994 Sep 15; 153(6):2738-49.
    View in: PubMed
    Score: 0.026
  14. Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J Immunol. 2004 Dec 15; 173(12):7135-9.
    View in: PubMed
    Score: 0.013
  15. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol. 2003 Dec; 4(12):1206-12.
    View in: PubMed
    Score: 0.012
  16. CD28/B7 regulation of anti-CD3-mediated immunosuppression in vivo. J Immunol. 2003 Feb 01; 170(3):1510-6.
    View in: PubMed
    Score: 0.012
  17. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol. 2000 Dec 01; 165(11):6606-11.
    View in: PubMed
    Score: 0.010
  18. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases. J Immunol. 1999 Feb 01; 162(3):1270-7.
    View in: PubMed
    Score: 0.009
  19. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J Immunol. 1997 Jul 01; 159(1):144-51.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.